These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24457244)

  • 41. NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primary.
    Shehata BM; Steelman CK; Abramowsky CR; Olson TA; French CA; Saxe DF; Ricketts RR; Katzenstein HM
    Pediatr Dev Pathol; 2010; 13(6):481-5. PubMed ID: 20017639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NUT midline carcinoma.
    French CA
    Cancer Genet Cytogenet; 2010 Nov; 203(1):16-20. PubMed ID: 20951314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.
    French CA
    Pathol Int; 2018 Nov; 68(11):583-595. PubMed ID: 30362654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NUT midline carcinoma mimicking a germ cell tumor: a case report.
    Harada Y; Koyama T; Takeuchi K; Shoji K; Hoshi K; Oyama Y
    BMC Cancer; 2016 Nov; 16(1):895. PubMed ID: 27855672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case of NUT midline carcinoma with no HPV infection, slight EWSR1 rearrangement and strong expression of EGFR.
    Maffini F; French CA; Cameron MJ; Stufano V; Barberis M; Pisa E; Manzotti M; Cattaneo A; De Fiori E; Viale G
    Tumori; 2013; 99(4):e152-5. PubMed ID: 24326851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case of endobronchial NUT midline carcinoma with intraluminal growth.
    Watanabe S; Hirano S; Mine S; Yoshida A; Motoi T; Ishii S; Naka G; Takeda Y; Igari T; Sugiyama H; Kobayashi N
    Anticancer Res; 2015 Mar; 35(3):1607-12. PubMed ID: 25750317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.
    Achcar Rde O; Nikiforova MN; Dacic S; Nicholson AG; Yousem SA
    Hum Pathol; 2009 Jun; 40(6):854-60. PubMed ID: 19269006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma.
    Yan J; Diaz J; Jiao J; Wang R; You J
    J Biol Chem; 2011 Aug; 286(31):27663-75. PubMed ID: 21652721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NUT Carcinoma in a Patient with Unusually Long Survival and False Negative FISH Results.
    McLean-Holden AC; Moore SA; Gagan J; French CA; Sher D; Truelson JM; Bishop JA
    Head Neck Pathol; 2021 Jun; 15(2):698-703. PubMed ID: 32918711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.
    Tanaka M; Kato K; Gomi K; Yoshida M; Niwa T; Aida N; Kigasawa H; Ohama Y; Tanaka Y
    Am J Surg Pathol; 2012 Mar; 36(3):381-8. PubMed ID: 22301500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Novel NUTM1-NSMCE2 Fusion Gene in a Pediatric Chest NUT Carcinoma.
    De Leonardis F; Greco Miani V; Vallese S; Barresi S; Marulli G; Novielli C; Dall'Igna P; Maruccia M; Santoro N
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):e322-e326. PubMed ID: 38775398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.
    Bishop JA; French CA; Ali SZ
    Cancer Cytopathol; 2016 Dec; 124(12):901-908. PubMed ID: 27400194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.
    Chen M; Chen X; Zhang Y; Wang W; Jiang L
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6361-6370. PubMed ID: 36752907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.
    Stelow EB; Bellizzi AM; Taneja K; Mills SE; Legallo RD; Kutok JL; Aster JC; French CA
    Am J Surg Pathol; 2008 Jun; 32(6):828-34. PubMed ID: 18391746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case report of a pan-cytokeratin negative NUT midline carcinoma of pulmonary origin, a BRD3-NUT variant: Challenges in cytomorphologic presentation.
    Hwang J; Marinelli L; Chormanski D; Rose H; Williams G; Adams T; Van Dellen M
    Diagn Cytopathol; 2023 Jul; 51(7):E209-E213. PubMed ID: 37021735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiation of NUT midline carcinoma by epigenomic reprogramming.
    Schwartz BE; Hofer MD; Lemieux ME; Bauer DE; Cameron MJ; West NH; Agoston ES; Reynoird N; Khochbin S; Ince TA; Christie A; Janeway KA; Vargas SO; Perez-Atayde AR; Aster JC; Sallan SE; Kung AL; Bradner JE; French CA
    Cancer Res; 2011 Apr; 71(7):2686-96. PubMed ID: 21447744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.
    Allison DB; Rueckert J; Cornea V; Lee CY; Dueber J; Bocklage T
    Endocr Pathol; 2022 Jun; 33(2):315-326. PubMed ID: 34997561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NUT Carcinoma in the Pelvic Cavity With Unusual Pathologic Features.
    Jung M; Kim SI; Kim JW; Jeon YK; Lee C
    Int J Gynecol Pathol; 2022 May; 41(3):292-297. PubMed ID: 34166280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland.
    Ziai J; French CA; Zambrano E
    Head Neck Pathol; 2010 Jun; 4(2):163-8. PubMed ID: 20352379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful treatment of a child with t(15;19)-positive tumor.
    Mertens F; Wiebe T; Adlercreutz C; Mandahl N; French CA
    Pediatr Blood Cancer; 2007 Dec; 49(7):1015-7. PubMed ID: 16435379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.